Fact CheckerSign in

NCT06439706Completed

HPV Self-sampling for Underscreened Latinas

Assessing the Feasibility and Acceptability of Juntas Contra el Virus Del Papiloma Humano, an HPV Self-sampling Intervention for Underscreened Latinas

Source: ClinicalTrials.gov · Last updated 3 Sept 2026

Brief summary (registry, in English)

The goal of this study is to learn if women of Hispanic/Latina ethnicity are willing to self-collect a cervico-vaginal sample for HPV testing. The main question the study will answer is: • Does a brief educational intervention increase the feasibility and acceptability of HPV self-sampling among Hispanic/Latina women? The study team will compare whether including a brief educational intervention with a mailed HPV self-sampling kit is more acceptable than receiving a mailed HPV self-sampling kit alone. Participants will be asked to complete surveys at study entry (baseline) and then randomized to receive only the HPV self-sampling kit, or the kit plus a small group education that meets with a bilingual health educator. Participants will then be contacted about one-month later to complete a follow-up survey. The study team will also measure the number of participants in each group who self-collect a sample and mail it in for HPV testing.

Status (registry)
Completed
Study type
Interventional
Enrollment
108 (actual)
First submitted
28 May 2024
Start date
4 Oct 2023
Primary completion date
30 Sept 2024
Lead sponsor
Fox Chase Cancer Center
NCT number
NCT06439706

What you commit to

  • Study type: Interventional
  • Participants enrolled: 108
  • From 4 Oct 2023 to the primary completion date, 30 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior diagnosis of cervical cancer or abnormality (e.g., dysplasia)

Other illness

  • Compromised immune system (e.g., known HIV)

Other

  • Had a hysterectomy/removal of the cervix
  • Women who self-report that they are pregnant or are within three months after a pregnancy

Who the study is looking for

  • Self-reported Hispanic/Latina ethnicity
  • Assigned female sex at birth
  • Age 30-65, consistent with guidelines for HPV DNA testing for cervical cancer screening
  • Speak and read English or Spanish
  • Computer or other device with internet connection
  • Overdue for cervical cancer screening (e.g., no cytology-based screening within the past 3 years; no hrHPV testing either alone or in combination with cytology in the past 5 years).

Age in the registry: 30 years to 65 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fox Chase Cancer Center
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.